Suppression of metastasis of human pancreatic cancer cells to the liver by small interfering RNA-mediated targeting of the midkine gene

The present study aimed to ascertain whether suppression of midkine (MK) expression in pancreatic cancer cells inhibits metastasis to the liver. Human pancreatic cancer AsPC-1 cells were transfected with small interfering RNA (siRNA) targeting MK. siRNA against MK was observed to reduce the expression of MK mRNA and protein in a concentration- and time-dependent manner, and to decrease the number of migrating and tissue-penetrating cells in a concentration-dependent manner (P<0.005). Extracellular vascular endothelial growth factor (VEGF) concentrations were markedly reduced for the siRNA-transfected cells compared with those that were non-siRNA-transfected. The liver transmission rate and tumor nodule number in the animals harboring the siRNA-transfected cells were lower compared with those in the animals harboring the non-siRNA-transfected cells (P<0.005). These data indicate that metastasis of pancreatic cancer cells to the liver requires the expression of MK. The downregulation of VEGF expression is essential to the mechanism whereby suppression of MK expression constrains the metastasis of pancreatic cancer cells to the liver.

[1]  H. Friess,et al.  Resection of Primary Pancreatic Cancer and Liver Metastasis: A Systematic Review , 2009, Digestive Surgery.

[2]  Hua Li,et al.  Inhibition of signal transducer and activator of transcription 3 expression by RNA interference suppresses invasion through inducing anoikis in human colon cancer cells. , 2008, World journal of gastroenterology.

[3]  S. Natsugoe,et al.  Clinical significance of midkine expression in pancreatic head carcinoma , 2007, British Journal of Cancer.

[4]  N. Auersperg,et al.  An improved assay to quantitate the invasiveness of cells in modified Boyden chambers , 2007, In Vitro Cellular & Developmental Biology - Animal.

[5]  T. Tajiri,et al.  Re-expression of reduced VEGF activity in liver metastases of experimental pancreatic cancer. , 2005, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[6]  P. Morel,et al.  Lymphatic Vessel Density and Vascular Endothelial Growth Factor-C Expression Correlate with Malignant Behavior in Human Pancreatic Endocrine Tumors , 2004, Clinical Cancer Research.

[7]  L. Ellis,et al.  Role of angiogenesis in the development and growth of liver metastasis , 2002, Annals of Surgical Oncology.

[8]  I. Fidler,et al.  Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  T. Fukuda,et al.  High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma , 2000, Cancer.

[10]  T. Muramatsu,et al.  Midkine, a retinoic acid-inducible heparin-binding cytokine in inflammatory responses: chemotactic activity to neutrophils and association with inflammatory synovitis. , 1997, Journal of biochemistry.

[11]  S. Takao,et al.  Increased Midkine Gene Expression in Human Gastrointestinal Cancers , 1995, Japanese journal of cancer research : Gann.

[12]  F. Yu.  Inhibition of telomerase activity in colon cancer LS-174T cells with liposome-mediated cripto antisense oligodeoxynucleotide , 2006 .

[13]  L. Rydén,et al.  Assessment of microvessel density in core needle biopsy specimen in breast cancer. , 2004, Anticancer research.

[14]  L. Ellis,et al.  Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis. , 2003, Annals of Surgical Oncology.

[15]  L. Ellis,et al.  New Approaches to the Treatment of Hepatic Malignancies Angiogenesis and Antiangiogenic Therapy of Colon Cancer Liver Metastasis , 2003, Annals of Surgical Oncology.